Maslovsky I, Volchek L, Blumental R, Ducach A, Lugassy G, Persistent paraneoplastic neurologic syndrome after successful therapy of Hodgkin's disease, in Eur. J. Haematol., vol. 66, n. 1, gennaio 2001, pp. 63–5, PMID11168510.
Atra A, Higgs E, Capra M, et al., ChlVPP chemotherapy in children with stage IV Hodgkin's disease: results of the UKCCSG HD 8201 and HD 9201 studies, in Br. J. Haematol., vol. 119, n. 3, dicembre 2002, pp. 647–51, PMID12437639.
Schellong G, Brämswig JH, Hörnig-Franz I, Schwarze EW, Pötter R, Wannenmacher M, Hodgkin's disease in children: combined modality treatment for stages IA, IB, and IIA. Results in 356 patients of the German/Austrian Pediatric Study Group, in Ann. Oncol., 5 Suppl 2, 1994, pp. 113–5, PMID8204510.
Desch CE, Lasala MR, Smith TJ, Hillner BE, The optimal timing of autologous bone marrow transplantation in Hodgkin's disease patients after a chemotherapy relapse, in J. Clin. Oncol., vol. 10, n. 2, febbraio 1992, pp. 200–9, PMID1531067.